AI Terminal
Heidelberg Pharma AG
Declaration of Voting Results & Voting Rights Announcements • May 5, 2020
201_dva_2020-05-05_9ee58061-3d70-404e-bef9-165d68f3e346.html
Declaration of Voting Results & Voting Rights Announcements
Open in ViewerOpens in native device viewer
News Details
Voting Rights Announcements | 5 May 2020 10:42
Heidelberg Pharma AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Heidelberg Pharma AG
05.05.2020 / 10:42
Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
| Name: | Heidelberg Pharma AG |
| Street: | Schriesheimer Str. 101 |
| Postal code: | 68526 |
| City: | Ladenburg Germany |
| Legal Entity Identifier (LEI): | 391200E09XYBYITR1W32 |
2. Reason for notification
| X | Acquisition/disposal of shares with voting rights |
| Acquisition/disposal of instruments | |
| Change of breakdown of voting rights | |
| Other reason: |
3. Details of person subject to the notification obligationNatural person (first name, surname): Dietmar Hopp
Date of birth: 26 Apr 1940
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
dievini Hopp BioTech holding GmbH & Co. KG; DH-Holding Verwaltungs GmbH
5. Date on which threshold was crossed or reached:29 Apr 2020
6. Total positions
| % of voting rights attached to shares (total of 7.a.) |
% of voting rights through instruments (total of 7.b.1 + 7.b.2) |
Total of both in % (7.a. + 7.b.) |
Total number of voting rights pursuant to Sec. 41 WpHG | |
| New | 76.68 % | 0.00 % | 76.68 % | 31030572 |
| Previous notification | 74.99 % | 0.00 % | 74.99 % | / |
7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
| ISIN | Absolute | In % | ||
| Direct (Sec. 33 WpHG) |
Indirect (Sec. 34 WpHG) |
Direct (Sec. 33 WpHG) |
Indirect (Sec. 34 WpHG) |
|
| DE000A11QVVo | 171538 | 23623686 | 0.55 % | 76.13 % |
| Total | 23795224 | 76.68 % |
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
| Type of instrument | Expiration or maturity date | Exercise or conversion period | Voting rights absolute | Voting rights in % |
| % | ||||
| Total | % |
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
| Type of instrument | Expiration or maturity date | Exercise or conversion period | Cash or physical settlement | Voting rights absolute | Voting rights in % |
| % | |||||
| Total | % |
8. Information in relation to the person subject to the notification obligation
| Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). | |
| X | Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: |
| Name | % of voting rights (if at least 3% or more) | % of voting rights through instruments (if at least 5% or more) | Total of both (if at least 5% or more) |
| Zurechnungsstrang 1 – attribution of shares 1 | % | % | % |
| Herr Dietmar Hopp | – % | – % | – % |
| DH-Holding GmbH & Co. KG | – % | – % | – % |
| DH-Holding Verwaltungs GmbH | 3.02 % | – % | – % |
| Zurechnungsstrang 2 – attribution of shares 2 | % | % | % |
| Herr Dietmar Hopp | – % | – % | – % |
| Hopp LT Vermögensverwaltungs GmbH | – % | – % | – % |
| DH-Capital GmbH & Co. KG | – % | – % | – % |
| dievini Hopp BioTech holding GmbH & Co. KG | 73.12 % | – % | 73.12 % |
| Zurechnungsstrang 3 – attribution of shares 3 | % | % | % |
| Herr Dietmar Hopp | – % | – % | – % |
| DH Verwaltungs GmbH | – % | – % | – % |
| DH-Capital GmbH & Co. K | – % | – % | – % |
| dievini Hopp BioTech holding GmbH & Co. KG | 73.12 % | – % | 73.12 % |
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)
Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
| Proportion of voting rights | Proportion of instruments | Total of both |
| % | % | % |
10. Other explanatory remarks:
Date
30 Apr 2020
05.05.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Heidelberg Pharma AG |
| Schriesheimer Str. 101 | |
| 68526 Ladenburg | |
| Germany | |
| Internet: | www.heidelberg-pharma.com |
| End of News | DGAP News Service |